Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
09/2005
09/15/2005US20050203049 Modulating the ability of a cell to affect the glycosylation state of a target selected from a lipid and a polypeptide by modulating the activity of an enzyme of either 47169 or 33935 protein; cell signaling; differentiation; tumorigenesis
09/15/2005US20050203039 Lymphoblast proteolytic enzyme which is secreted from human b lymphoblastic cells and recognizes and destroys bacterial DNA; bactericides
09/15/2005US20050203031 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions
09/15/2005US20050203026 Rosacea; vascular endothelial growth factor inhibitors; protease inhibitors such as Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor
09/15/2005US20050203021 Identifying prorenin modulators for treatment of cardiovascular and organ hypertrophy; enzyme inhibitors; mimetics; blood pressure; arterial thickening
09/15/2005US20050203010 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
09/15/2005US20050202552 Proteins producing an altered immunogenic response and methods of making and using the same
09/15/2005US20050202551 Proteins producing an altered immunogenic response and methods of making and using the same
09/15/2005US20050202550 Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE10A) and uses thereof
09/15/2005US20050202549 Phosphodiesterase crystal for identifying modulators for use in treatment and prevention of sexual, pain and psychological disorders; drug screening and design
09/15/2005US20050202548 Mammalian enzymatic polypeptide for use as tool in designing drugs which prevent and treat hypercholesterolemia, hyperlipemia, arteriosclerosis, parasitic infection, cell proliferative and vascular diseases
09/15/2005US20050202547 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy
09/15/2005US20050202546 mixing an egg white or its diluted solution with diatomaceous earth, kaolin, zeolite or the mixtures thereof, followed by eluting adsorbed lysozyme with a salt solution.
09/15/2005US20050202545 Methods for producing optically active alpha-hydroxy amides
09/15/2005US20050202540 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene
09/15/2005US20050202535 Fusion protein comprising bowman-kirk, soybean trypsin and eglin C inhibitors for use in treatment and prevention of inflammatory, arthritic and skin disorders
09/15/2005US20050202533 Maltogenic alpha-amylase variants
09/15/2005US20050202528 Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof
09/15/2005US20050202527 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants
09/15/2005US20050202526 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/15/2005US20050202520 Has a histidine tag and where the subdomain of the IMPDH polypeptide is modified so that the rate stability of the modified polypeptide is maintained relative to the wild-type IMPDH polypeptide
09/15/2005US20050202519 Mutated abl kinase domains
09/15/2005US20050202505 Using oxidoreductase to determine inhibitory effects of 2-acetylbenzofuran; diagnosis and treatment of psychological disorders
09/15/2005US20050202502 Oxaloacetate hydrolase deficient fungal host cells
09/15/2005US20050202496 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/15/2005US20050202494 Catalases
09/15/2005US20050202486 Expression vector comprising nucleotide sequences coding inositol 1,3,4-trisphosphate 5/6-kinase for use in transfomation of plants and enhancement of non-phytate phosphorous production in corn, soy and animal feeds
09/15/2005US20050202480 Stabilization of linear double-stranded DNA in the presence of exonucleases
09/15/2005US20050202478 Phosphodiesterases
09/15/2005US20050202475 Using chimeric membrane protein as diagnostic/prognostic indicator of cell proliferative disorders
09/15/2005US20050202474 Phosphodiesterases
09/15/2005US20050202452 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein
09/15/2005US20050202443 Type II restriction endonuclease and application thereof
09/15/2005US20050202438 Using site directed mutagenesis to generate polypeptide of preferential function; two dimensional sequence analysis
09/15/2005US20050202437 Expression vector comprised of lactobacillus and heterologous gene sequences for use as gene therapeutic tools; enhancing expression of exogenous gene sequences
09/15/2005US20050202425 expression vector; host cell transformed with gene; culturing cell to produce polypeptide that has an activity of converting a sulfated fucogalactan into a smaller molecule
09/15/2005US20050202419 Peroxide-driven cytochrome P450 oxygenase variants
09/15/2005US20050202040 Methods for large scale productions of recombinant DNA-derived tPA or K2S molecules
09/15/2005US20050202002 Reagent; polyclonal or monoclonal antibody against the protease or its proenzyme which activates blood clotting factor VII, is inhibited by the presence of aprotinin, is increased in its activity by calcium ions, heparin, or heparin related substance
09/15/2005US20050202001 Enhancement of human epidermal melanogenesis
09/15/2005US20050201999 Compounds and methods for identifying compounds which inhibit a new class of aspartyl proteases
09/15/2005US20050201984 An adenoviral genome replaced with a therapeutic gene or DNA sequence regulated by a ubiquitous promoter either a Cytomegalo virus promotor or a tissue-specific phosphoenolpyruvate carboxykinase promoter, where gene or sequence encodes for a latent human metalloprotease gene MMP-8 (collengenases)
09/15/2005US20050201962 Modified Porphyran
09/15/2005DE102004010131A1 Anhydrofructose-Reductase, ihre kodierende Nukleotidsequenz und deren Verwendung Anhydrofructose reductase, their coding nucleotide sequence and their use
09/15/2005DE102004009161A1 Producing defined enzyme mixture and/or metabolite mixture for fermentation of target substrates, by inoculating microorganisms in solid-phase bioreactor with inducer substrates and keeping mixed culture under appropriate conditions
09/15/2005DE102004007624A1 Preparation of ketocarotenoids, useful in foods and animal feeds, by growing genetically modified organism, particularly plant, having altered ketolase activity
09/15/2005DE102004005836A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A method for producing L-amino acids using strains of the family Enterobacteriaceae
09/15/2005CA2598687A1 Flavonoids
09/15/2005CA2563397A1 Adzymes and uses thereof
09/15/2005CA2559114A1 Compounds for hydrolysing ribonucleic acids (rnas)
09/15/2005CA2558960A1 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
09/15/2005CA2558593A1 .beta.-fructofuranosidase variants
09/15/2005CA2558433A1 Granulate containing a functional food ingredient and method for the manufacture thereof
09/15/2005CA2557854A1 Method for improving productivity of plant by chloroplast technology
09/15/2005CA2554966A1 Methods and compostions for targeted cleavage and recombination
09/15/2005CA2553734A1 Rna-dependent dna polymerase from geobacillus stearothermophilus
09/14/2005EP1574580A2 Transgenic plants expressing cellulolytic enzymes
09/14/2005EP1574579A2 Outer surface proteins, their genes, and their use
09/14/2005EP1574573A2 Compositions and methods for genetic modification of plants
09/14/2005EP1574572A1 Compounds for hydrolysing ribonucleic acids (RNAs)
09/14/2005EP1574569A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same
09/14/2005EP1574568A1 D-aminoacylase
09/14/2005EP1574567A1 Novel xylanases and their use
09/14/2005EP1574565A1 Method of selecting escherichia coli strain overexpressing foreign gene, escherichia coli mutant thus selected and process for producing enzyme and compound using the same
09/14/2005EP1574520A2 Methods and materials relating to neuronal guidance molecule-like (NGM-like) polypeptides and polynucleotides
09/14/2005EP1573441A2 The cop protein design tool
09/14/2005EP1573324A2 Cytochrome c acetylation
09/14/2005EP1573052A1 Method of selecting a lipolytic enzyme
09/14/2005EP1573030A2 Irak-m is a negative regulator of toll-like receptor signaling
09/14/2005EP1573026A2 Mre11: modulation of cellular proliferation
09/14/2005EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
09/14/2005EP1573008A2 Polynucleotides targeted against htert and use thereof
09/14/2005EP1573000A2 Crystal structure of glutamate racemase (muri)
09/14/2005EP1572999A1 Method of diagnosis of obesity
09/14/2005EP1572998A2 Serine protease
09/14/2005EP1572997A1 Subtilisin variants, with improved perhydrolase activity
09/14/2005EP1572996A2 Detergent composition comprising endo-glucanase
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572994A2 Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
09/14/2005EP1572993A2 Novel choline oxidases
09/14/2005EP1572991A2 Compositions and methods for hydroxilating epothilones
09/14/2005EP1572987A2 Novel nucleic acids and polypeptides
09/14/2005EP1572977A2 Assay and compositions for detection of bacillus anthracis nucleic acid
09/14/2005EP1572973A2 Mracs as modifiers of the rac pathway and methods of use
09/14/2005EP1572966A2 Complete biosynthetic gene set for synthesis of polyketide antibiotics, including the albicidin family, resistance genes and uses thereof
09/14/2005EP1572959A2 Hybrid protein methods and compositions
09/14/2005EP1572953A2 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42
09/14/2005EP1572940A2 Ribulose 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572928A2 Plant acyl-coa synthetases
09/14/2005EP1572926A2 Polynucleotide encoding a novel cysteine protease of the calpain superfamily, protease-42
09/14/2005EP1572920A2 Semisynthetic protein-based site-directed probes for identification and inhibition of active sites, and methods therefor
09/14/2005EP1572914A2 Lambda integrase mediated recombination in plants
09/14/2005EP1572911A2 Cloning of cytochrome p450 genes from nicotiana
09/14/2005EP1572907A2 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
09/14/2005EP1572906A2 Novel nucleic acid molecules and polypeptides encoding baboon tafi
09/14/2005EP1572904A2 Modified bace
09/14/2005EP1572898A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572897A2 Ordered biological nanostructures formed from chaperonin polypeptides
1 ... 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 ... 1416